Dapagliflozin-induced long-term and severe anorexia and weight loss: An extraordinary case.
作者信息
Cure Erkan, Sirin Hakan, Cure Medine Cumhur, Sahin Dursun Ali
机构信息
Department of Internal Medicine, Ota and Jinemed Hospital, Istanbul, Turkey.
Department of Urology, Basaksehir Cam ve Sakura City Hospital, Istanbul, Turkey.
出版信息
Indian J Pharmacol. 2021 Mar-Apr;53(2):174-175. doi: 10.4103/ijp.IJP_785_19.
Abstract
摘要
相似文献
1
Dapagliflozin-induced long-term and severe anorexia and weight loss: An extraordinary case.
Indian J Pharmacol. 2021 Mar-Apr;53(2):174-175. doi: 10.4103/ijp.IJP_785_19.
2
Dapagliflozin-induced hypercalcemia.
Nefrologia (Engl Ed). 2018 May-Jun;38(3):336-337. doi: 10.1016/j.nefro.2017.06.009. Epub 2017 Aug 1.
3
Dapagliflozin-induced sweet syndrome.
Cutis. 2019 Aug;104(2):E22-E24.
4
Fournier's gangrene in a patient on dapagliflozin treatment for type 2 diabetes.
J Diabetes. 2019 May;11(5):348-350. doi: 10.1111/1753-0407.12896. Epub 2019 Feb 5.
5
Dapagliflozin-Associated Diabetic Ketoacidosis.
Am J Ther. 2018 Nov/Dec;25(6):e765-e766. doi: 10.1097/MJT.0000000000000770.
6
Dapagliflozin associated ketoacidosis: A must know fact for nephrologists.
Nephrology (Carlton). 2018 Feb;23(2):192. doi: 10.1111/nep.13039.
7
Low carbohydrate diet while taking dapagliflozin: A case report and review of literature.
Diabetes Metab Syndr. 2021 Jan-Feb;15(1):361-363. doi: 10.1016/j.dsx.2021.01.016. Epub 2021 Jan 23.
8
Dapagliflozin (SGLT2-i) induced euglycaemic diabetic ketoacidosis.
BMJ Case Rep. 2019 Sep 19;12(9):e231104. doi: 10.1136/bcr-2019-231104.
9
Fournier's gangrene and SGLT2 inhibitors: A case study.
Endocrinol Diabetes Nutr (Engl Ed). 2020 Jun-Jul;67(6):423-425. doi: 10.1016/j.endinu.2019.12.007. Epub 2020 Apr 27.
10
Euglisemic diabetic ketoacidotic coma caused by dapagliflozin.
Am J Emerg Med. 2018 Nov;36(11):2136.e1-2136.e2. doi: 10.1016/j.ajem.2018.08.054. Epub 2018 Aug 21.
本文引用的文献
1
Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors: A Clinician's Guide.
Diabetes Metab Syndr Obes. 2019 Oct 14;12:2125-2136. doi: 10.2147/DMSO.S212003. eCollection 2019.
2
Differential pharmacology and clinical utility of dapagliflozin in type 2 diabetes.
Clin Pharmacol. 2019 Sep 19;11:133-143. doi: 10.2147/CPAA.S172353. eCollection 2019.
3
Long-Term Weight Loss With Metformin or Lifestyle Intervention in the Diabetes Prevention Program Outcomes Study.
Ann Intern Med. 2019 May 21;170(10):682-690. doi: 10.7326/M18-1605. Epub 2019 Apr 23.
Zotero 插件